Medicine Overview of Glimkap PM 1 Tablet
Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Headache, Edema, Weight gain, Anemia, Blurred vision, Bone fracture, Upper respiratory tract infection.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimkap PM 1 Tablet is to be taken with food.
Glimkap PM 1 Tablet may cause stomach upset if taken empty stomach.
Glimkap PM 1 Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin, pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which also increases the body's sensitivity to insulin.
In Depth Information on Glimkap PM 1 Tablet
Glimkap PM Tablet related warnings
Taking pioglitazone with alcohol may affect blood glucose levels in patients with diabetes.
WEIGH RISKS VS BENEFITS
Glimkap PM 1 Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Glimkap PM 1 Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Monitor the breastfed baby’s blood sugar during treatment with Glimkap PM 1 Tablet
Your ability to drive may be affected if your blood sugar is
low or high. If this happens, do not drive.
Glimkap PM 1 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimkap PM 1 Tablet may be needed. Please consult your doctor.
Use of Glimkap PM 1 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Glimkap PM 1 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimkap PM 1 Tablet may be needed. Please consult your doctor.
Use of Glimkap PM 1 Tablet is not recommended in patients with severe liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Glimkap PM 1 Tablet
What are you using this medicine for?
Survey Participants: 1
“The following are the results of on-going survey on 1mg.com for Glimkap PM 1 Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Glimkap PM 1 Tablet: PVP, DGN, DPP, SSA, SWA, VRS, GTC, HBV, PWN, BSN, NSL, RHW, NXG, SDM, SAF, MDO, FGH, UMP, JVN, ANT, LCC, HIP, MAX, SBA, OHM, ATL, THP, ARD, HAT, JMJ, STA, DYG, NWP, AYU, LHA, RSA, MLC, DFP, KHH, RHL, RSS, ZVP, USF, GNC, IPL, EMB, DDR, IAD, HGI, OLT, OIP, OWP, SWP, HMP, DLP, SCH, TRP, NTB, GPP, ZEL, SJP, DHR, PTI, RPP, SAT, PRN, TNH, WSI, SHD, SGC, NDP, RJH, SYN, INC, GTK, ADT, DPL, NVY, HPC, JIV, AMR, ATP, ABP, MAM, SVH, RUS, PLT, BMJ, HEX, RWP, NVL, AAY, WHL, AGT, JVO, BDN, BAL, GPT, BHP, MMS, NNH, SBL, BBS, BTM, MSD, SHP, ENP, 9T9, MPC, AAR, BIO, GBL, MAK, PNT, EQN, MOM, RKS, AVN, PEN, CLT, PPR